Janux Therapeutics and Bristol Myers Squibb (BMS) are developing a tumor-activated therapeutic in an exclusive licensing agreement.

Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October ...

For the fourth consecutive year, Vetter has been recognized by the internationally renowned EcoVadis sustainability ranking, ...

Gannet BioChem, a specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity ...

Rentschler Biopharma SE has appointed Detra Glinatsis as Head of Business Development U.S., where she will lead all business ...

Datwyler says it has developed a first-to-market universal plunger for large-volume cartridges containing up to 20mL.

The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.

Ember LifeSciences Inc., a provider of cold chain technology, has appointed Ann Hyllengren as Chief Financial Officer to ...

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, names Jolie Siegel Executive Vice President and General ...

Daiichi Sankyo has expanded its presence in Canada with the official opening of its permanent headquarters in Toronto, ...

Crystalys Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Justin Thacker as Chief Financial Officer (CFO).

Charles River Laboratories International Inc. and Gazi University Faculty of Medicine have entered a gene therapy CDMO ...